Female Stimulant

Product NDC

43742-1507

11-digit product format

437421507

Labeler code

43742

Product ID

43742-1507_98b646e4-e71f-46d3-9094-778235b7af46

Type

HUMAN OTC DRUG

Nonproprietary name

Lilium Tigrinum, Bovista, Cypripedium Pubescens, Hydrastis Canadensis, Petroselinum Sativum, Aquilegia Vulgaris, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Heart (Suis), Kreosotum, Oophorinum (Suis), Uterus (Suis), Folliculinum, Lachesis Mutus, Magnesia Phosphorica, Mercurius Solubilis, Sepia, Pineal Gland (Suis), Hypophysis Suis, Aconiticum Acidum CIS-, Apis Venenum Purum, Estradiol, Progesterone, Testosterone, Placenta Totalis Suis, Faecalis (Alkaligenes), Mutabile Bacillus (Bach)

Dosage form

LIQUID

Route

ORAL

Labeler

Deseret Biologicals, Inc.

Marketing category

UNAPPROVED HOMEOPATHIC

Marketing start

2019-08-20

Marketing end

2030-01-02

Substance

ACONITIC ACID, (Z)-; ALCALIGENES FAECALIS; APIS MELLIFERA VENOM; AQUILEGIA VULGARIS; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; ESCHERICHIA COLI; ESTRADIOL; ESTRONE; GOLDENSEAL; LACHESIS MUTA VENOM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPERDON UTRIFORME FRUITING BODY; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MERCURIUS SOLUBILIS; PETROSELINUM CRISPUM WHOLE; PORK HEART; PROGESTERONE; SEPIA OFFICINALIS JUICE; SUS SCROFA ADRENAL GLAND; SUS SCROFA OVARY; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; SUS SCROFA UTERUS; TESTOSTERONE; WOOD CREOSOTE

Active strength

10; 30; 18; 8; 6; 30; 30; 8; 6; 10; 4; 6; 10; 12; 6; 8; 30; 13; 8; 8; 16; 10; 6; 8; 8; 30; 8 [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL

Pharmacologic classes

Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Calculi Dissolution Agent [EPC], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Progesterone [CS], Progesterone [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

DEA schedule

CIII

NDC exclude flag

No

Current FDA listing

Yes